WHO Executive Board To Address Wide Range Of Topics At 144th Session, From Agency’s Budget To Access To Medicines

Intellectual Property Watch: Special Report: Guide To This Week’s WHO Board Meeting — Budget, Medicines Access, Antimicrobial Resistance, NCDs, More
“The World Health Organization Executive Board this month will consider an eight percent WHO budget increase for 2020-2021, discuss environment health risks, the high price of cancer drugs, and how to facilitate access to medicines and vaccines. Also on the agenda is the fight against antimicrobial resistance, rising noncommunicable diseases, and tuberculosis. In another area, the Board is also expected to discuss its pandemic influenza framework … The 144th session of the WHO Executive Board (EB) is taking place from 24 January-1 February…” (Saez, 1/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.